Search Results 1301-1310 of 12948 for immunosuppressant drugs

  1. Surgery - Clinical trials

    Defining the Immunologic Profile of Sentinel Lymph Nodes and Identifying the Mechanisms Responsible for Immunosuppression. Rochester, Minn., Jacksonville, Fla.

  2. A Study To Evaluate The Efficacy And Safety Of Ruxolitinib Cream In Participants With Cutaneous Lichen Planus - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health Letter · Healthy Lifestyle. Featured conditions. Brain tumor, breast cancer ...

  3. Recent findings and future directions in non-Hodgkin's lymphoma therapy - Mayo Clinic

    Cancerous cells overexpressing immunosuppressive ligands; Cytokine secretion leading to immune exhaustion or immune activation suppression. Background for the ...

  4. Study To Evaluate The Safety, Tolerability And Preliminary Antitumor Activity Of INCB059872 In Patients With Relapsed/Refractory Ewing Sarcoma - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... immunosuppressive therapy following allogeneic ... drug administration, New York Heart Association ...

  5. Pharmacokinetics And Pharmacodynamic Biomarkers Of Janus Kinase Inhibitor Therapy In Patients With Ulcerative Colitis (PROPHETIC Study) - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... Concomitant administration of biological therapies for UC or potent immunosuppressants, such as azathioprine ...

  6. Safety And Efficacy Of SA4Ag Vaccine In Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... immunosuppressant medications, including ... immunosuppressant medications, including monoclonal ...

  7. Paliperidone (intramuscular route) - Side effects & uses - Mayo Clinic

    Invega Sustenna® may also be used alone or in combination with other medicines to treat schizoaffective disorder. This medicine should not be used to treat ...

  8. Surgery - Clinical trials

    Defining The Immunologic Profile Of Sentinel Lymph Nodes And Identifying The Mechanisms Responsible For Immunosuppression. Jacksonville, Fla., Rochester, Minn.

  9. Investigation Of Ubamatamab Combination Therapy In Adult Participants With Platinum-Resistant Ovarian Cancer - Mayo Clinic

    ... drug is on its own and in combination with other anti-cancer drugs (bevacizumab, cemiplimab, fianlimab and a standard chemotherapy drug, pegylated liposomal ...

  10. Efficacy And Safety Of Tislelizumab In Combination With Fruquintinib In Participants With Selected Solid Tumors - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... immunosuppressive medication ≤ 14 days before the first dose of study drug(s), ...